INTS - Intensity Therapeutics Inc
IEX Last Trade
4.335
0.105 2.422%
Share volume: 8,805
Last Updated: Fri 30 Aug 2024 09:58:42 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$4.23
0.11
2.48%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
1.16%
1 Month
-9.75%
3 Months
-11.94%
6 Months
20.13%
1 Year
-25.64%
2 Year
-27.01%
Key data
Stock price
$4.34
DAY RANGE
N/A - N/A
52 WEEK RANGE
$2.01 - $11.44
52 WEEK CHANGE
-$0.23
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/11/2024
Company detail
CEO:
Region: US
Website:
Employees: 9
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website:
Employees: 9
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
intensity therapeutics is a connecticut based biopharmaceutical company whose mission is to create safer and more efficacious chemotherapy treatments. intensity therapeutics is a preclinical, in vivo stage company seeking investors interested in helping to advance the company’s technology and products.
Recent news